216 related articles for article (PubMed ID: 17702966)
1. Free and total cortisol levels as predictors of severity and outcome in community-acquired pneumonia.
Christ-Crain M; Stolz D; Jutla S; Couppis O; Müller C; Bingisser R; Schuetz P; Tamm M; Edwards R; Müller B; Grossman AB
Am J Respir Crit Care Med; 2007 Nov; 176(9):913-20. PubMed ID: 17702966
[TBL] [Abstract][Full Text] [Related]
2. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].
Christ-Crain M; Morgenthaler NG; Stolz D; Müller C; Bingisser R; Harbarth S; Tamm M; Struck J; Bergmann A; Müller B
Crit Care; 2006; 10(3):R96. PubMed ID: 16805922
[TBL] [Abstract][Full Text] [Related]
3. Adrenal response in severe community-acquired pneumonia: impact on outcomes and disease severity.
Salluh JIF; Bozza FA; Soares M; Verdeal JCR; Castro-Faria-Neto HC; Lapa E Silva JR; Bozza PT
Chest; 2008 Nov; 134(5):947-954. PubMed ID: 18753464
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic and prognostic power of biomarkers to improve the management of community acquired pneumonia in the emergency department].
Julián-Jiménez A; Timón Zapata J; Laserna Mendieta EJ; Sicilia-Bravo I; Palomo-de Los Reyes MJ; Cabezas-Martínez A; Laín-Terés N; Estebaran-Martín J; Lozano-Ancín A; Cuena-Boy R
Enferm Infecc Microbiol Clin; 2014 Apr; 32(4):225-35. PubMed ID: 24182623
[TBL] [Abstract][Full Text] [Related]
5. Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia.
Lee JH; Kim J; Kim K; Jo YH; Rhee J; Kim TY; Na SH; Hwang SS
J Crit Care; 2011 Jun; 26(3):287-94. PubMed ID: 21129911
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic and stratified value of adrenomedullin in community acquired pneumonia patients in emergency department].
Chen Y; Li C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Feb; 26(2):115-9. PubMed ID: 24524403
[TBL] [Abstract][Full Text] [Related]
7. Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia.
Courtais C; Kuster N; Dupuy AM; Folschveiller M; Jreige R; Bargnoux AS; Guiot J; Lefebvre S; Cristol JP; Sebbane M
Am J Emerg Med; 2013 Jan; 31(1):215-21. PubMed ID: 23000327
[TBL] [Abstract][Full Text] [Related]
8. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia.
Ugajin M; Yamaki K; Hirasawa N; Yagi T
Respir Care; 2014 Apr; 59(4):564-73. PubMed ID: 24170911
[TBL] [Abstract][Full Text] [Related]
9. [Coagulopathy correlates with outcomes in patients with community- acquired pneumonia].
Zhuang Q; Zeng Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):406-10. PubMed ID: 25200038
[TBL] [Abstract][Full Text] [Related]
10. Addition of vitamin D status to prognostic scores improves the prediction of outcome in community-acquired pneumonia.
Remmelts HH; van de Garde EM; Meijvis SC; Peelen EL; Damoiseaux JG; Grutters JC; Biesma DH; Bos WJ; Rijkers GT
Clin Infect Dis; 2012 Dec; 55(11):1488-94. PubMed ID: 22942205
[TBL] [Abstract][Full Text] [Related]
11. The value of procalcitonin level in community-acquired pneumonia in the ED.
Park JH; Wee JH; Choi SP; Oh SH
Am J Emerg Med; 2012 Sep; 30(7):1248-54. PubMed ID: 22030193
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of procalcitonin in community-acquired pneumonia.
Schuetz P; Suter-Widmer I; Chaudri A; Christ-Crain M; Zimmerli W; Mueller B;
Eur Respir J; 2011 Feb; 37(2):384-92. PubMed ID: 20595156
[TBL] [Abstract][Full Text] [Related]
13. Risk stratification and prediction value of procalcitonin and clinical severity scores for community-acquired pneumonia in ED.
Zhou H; Guo S; Lan T; Ma S; Zhang F; Zhao Z
Am J Emerg Med; 2018 Dec; 36(12):2155-2160. PubMed ID: 29691103
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index.
Masiá M; Gutiérrez F; Shum C; Padilla S; Navarro JC; Flores E; Hernández I
Chest; 2005 Oct; 128(4):2223-9. PubMed ID: 16236878
[TBL] [Abstract][Full Text] [Related]
15. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes.
Krüger S; Ewig S; Marre R; Papassotiriou J; Richter K; von Baum H; Suttorp N; Welte T;
Eur Respir J; 2008 Feb; 31(2):349-55. PubMed ID: 17959641
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia.
Menéndez R; Martínez R; Reyes S; Mensa J; Filella X; Marcos MA; Martínez A; Esquinas C; Ramirez P; Torres A
Thorax; 2009 Jul; 64(7):587-91. PubMed ID: 19131448
[TBL] [Abstract][Full Text] [Related]
17. Clinical risk scores and blood biomarkers as predictors of long-term outcome in patients with community-acquired pneumonia: a 6-year prospective follow-up study.
Alan M; Grolimund E; Kutz A; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Zimmerli W; Mueller B; Schuetz P;
J Intern Med; 2015 Aug; 278(2):174-84. PubMed ID: 25529395
[TBL] [Abstract][Full Text] [Related]
18. Use of B-type natriuretic peptide in the risk stratification of community-acquired pneumonia.
Christ-Crain M; Breidthardt T; Stolz D; Zobrist K; Bingisser R; Miedinger D; Leuppi J; Tamm M; Mueller B; Mueller C
J Intern Med; 2008 Aug; 264(2):166-76. PubMed ID: 18298480
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia.
Gordo-Remartínez S; Calderón-Moreno M; Fernández-Herranz J; Castuera-Gil A; Gallego-Alonso-Colmenares M; Puertas-López C; Nuevo-González JA; Sánchez-Sendín D; García-Gámiz M; Sevillano-Fernández JA; Álvarez-Sala LA; Andueza-Lillo JA; de Miguel-Yanes JM
PLoS One; 2015; 10(6):e0125212. PubMed ID: 26030588
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia.
Suberviola B; Castellanos-Ortega A; Llorca J; Ortiz F; Iglesias D; Prieto B
Swiss Med Wkly; 2012; 142():w13542. PubMed ID: 22430899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]